AP
Alnylam Pharmaceuticals, Inc.
🇧🇷BVMF.A1LN34BrazilHealthcare
R$63.74BRLup +1.04 (+1.66%)OpenEnd of day1:22 PM
PriceR$63.74+1.04 (+1.66%)
Profile
- Healthcare
- Biotechnology
- Brazil
Identity
- Exchange
- B3 - Brasil Bolsa Balcão . BVMF
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 2,230
- Headquarters
- Cambridge, Brazil
- Website
- https://www.alnylam.com
Market
- Shares outstanding
- 2.6B
- Market cap
- R$167.1B
Highlights
- Market cap
- R$167.1B
- EPS LTM
- -R$2.44
- P/E LTM
- -26.16calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- R$2.46B
- Net income
- -R$319.09M
- Gross margin
- 83.64%
- Free cash flow
- Not reported
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.